Aeluma earnings release, May 13, 2026
Aeluma Announces Third Quarter Fiscal 2026 Financial
Results
GOLETA, CA – May 13, 2026 – Aeluma,
Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a transformative semiconductor company specializing in high-performance and scalable technologies, today reported financial results for its third quarter of fiscal 2026 ended March 31, 2026.
Management Commentary
“This quarter reinforced Aeluma’s strategy as we have experienced a major uptick in commercial interest,” said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma.
“The massive AI data center buildout is outpacing the scale of the photonics supply chain. Customers are considering our technology to address near-term supply gaps, and for long-term growth opportunities.”
“The industry is experiencing constraints around indium phosphide technology that we highlighted years ago—and that dynamic is creating both urgency and opportunity for Aeluma,”
Dr. Klamkin continued. “These market forces validate the core thesis behind our platform and underscore the relevance of the solutions we’ve been developing.”
“We have made considerable progress in our commercialization path with important manufacturing partnerships to enable scaling, senior hires to support operations and strategy, and additional non-dilutive capital. With six new development engagements totaling $5 million in value, we have already met our objective of onboarding three to seven new contracts for fiscal 2026.”
“Our recent participation at the Optical
Fiber Communication (OFC) Conference reinforced that the industry is looking beyond short-term fixes and toward platforms that can enable long-term growth. That shift in perspective plays directly to Aeluma’s strengths. Beyond AI infrastructure, we continue to advance opportunities across mobile, defense, and quantum. Engagements are becoming more targeted and more closely aligned with commercialization paths,” concluded Dr. Klamkin.
Recent Company Highlights
Fiscal Q3 2026 Financial Results
Fiscal Year 2026 Guidance and Strategic Priorities
For the full fiscal year of 2026, Aeluma narrowed its previous revenue guidance to $4.2 million to $4.6 million from the previous range of $4.0 million to $6.0 million. Delays in execution of contracts, due to government shutdowns and other factors, led to postponement of initial start-of-work for several projects. The Company has made considerable progress on its strategic priorities for 2026, which emphasize manufacturing and commercialization moving forward:²
Conference Call and Webcast
Aeluma will host a conference call at 2:00 p.m.
Pacific Time / 5:00 p.m. Eastern Time on May 13, 2026, to discuss the Company’s financial results and business outlook. Interested participants may access the conference the call by dialing (877) 317-6789 (domestic) or (412) 317-6789 (international) and referencing
“Aeluma.” A live webcast of the call will be available on the “Investors” section of Aeluma’s website and can also be accessed by clicking here.
A replay of the conference call will be available on Aeluma’s website shortly after the call concludes.
Note about Non
-
GAAP Financial Measures
This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company’s financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma’s ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma’s results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.
This press release includes non-GAAP financial measures, including:
A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.³
Financial statements
Income Statement
Three Months Ended — Condensed Consolidated Statements of Operations (unaudited) ($ in thousands, except per share data)
| Three Months Ended – March 31, 2026 | Three Months Ended – December 31, 2025 | Three Months Ended – March 31, 2025 | Nine Months Ended – March 31, 2026 | Nine Months Ended – March 31, 2025 | ||
|---|---|---|---|---|---|---|
| Revenue | 1,222 | 1,272 | 1,255 | 3,879 | 3,348 | |
| Operating expenses: | Cost of revenue | 836 | 919 | 311 | 2,456 | 1,105 |
| Operating expenses: | Research and development | 882 | 906 | 471 | 2,394 | 1,130 |
| Operating expenses: | General and administrative | 1,629 | 1,528 | 1,305 | 4,843 | 2,287 |
| Operating expenses: | Total operating expenses | 3,347 | 3,353 | 2,087 | 9,693 | 4,522 |
| Operating expenses: | Loss from operations | -2,125 | -2,081 | -832 | -5,814 | -1,174 |
| Other income (expense): | Interest income | 325 | 228 | 3 | 668 | 3 |
| Other income (expense): | Amortization of discount on convertible notes | -287 | -715 | |||
| Other income (expense): | Changes in fair value of derivative liabilities | 2,577 | -278 | |||
| Other income (expense): | Total other income (expense), net | 325 | 228 | 2,293 | 668 | -990 |
| Other income (expense): | Income (loss) before income tax expense | -1,800 | -1,853 | 1,461 | -5,146 | -2,164 |
| Other income (expense): | Net income (loss) | -1,800 | -1,853 | 1,461 | -5,146 | -2,164 |
| Net income (loss) per share: | Basic | -0.1 | -0.11 | 0.12 | -0.3 | -0.18 |
| Net income (loss) per share: | Diluted | -0.1 | -0.11 | 0.11 | -0.3 | -0.18 |
| Weighted average common shares outstanding: | Basic | 18,061,402 | 17,875,930 | 12,472,061 | 17,354,370 | 12,286,284 |
| Weighted average common shares outstanding: | Diluted | 18,061,402 | 17,875,930 | 13,206,919 | 17,354,370 | 12,286,284 |
| Weighted average common shares outstanding: | Book value per share | 2.22 | 2.28 | 1.44 | 2.22 | 1.44 |
Income Statement
Three Months Ended — Reconciliation of GAAP and Non-GAAP Financial Measures (unaudited) ($ in thousands, except per share data)
| Three Months Ended – March 31, 2026 | Three Months Ended – December 31, 2025 | Three Months Ended – March 31, 2025 | Nine Months Ended – March 31, 2026 | Nine Months Ended – March 31, 2025 | ||
|---|---|---|---|---|---|---|
| GAAP net income (loss) | -1,800 | -1,853 | 1,461 | -5,146 | -2,164 | |
| Non-GAAP adjustments: | Stock-based compensation | 1,099 | 1,056 | 833 | 3,211 | 1,149 |
| Non-GAAP adjustments: | Consulting and advisory | 3 | 17 | |||
| Non-GAAP adjustments: | Amortization of discount on convertible notes | 287 | 715 | |||
| Non-GAAP adjustments: | Changes in fair value of derivative liabilities | -2,577 | 278 | |||
| Non-GAAP adjustments: | Total adjustments to GAAP net loss | 1,099 | 1,056 | -1,454 | 3,211 | 2,159 |
| Non-GAAP adjustments: | Non-GAAP net income (loss) | -701 | -797 | 7 | -1,935 | -5 |
| Non-GAAP adjustments: | Depreciation & amortization | 115 | 108 | 105 | 325 | 307 |
| Non-GAAP adjustments: | Interest income | -325 | -228 | -3 | -668 | -3 |
| Non-GAAP adjustments: | Adjusted EBITDA | -911 | -917 | 109 | -2,278 | 299 |
| Non-GAAP adjustments: | GAAP net income (loss) per share – basic | -0.1 | -0.11 | 0.12 | -0.3 | -0.18 |
| Non-GAAP adjustments: | Non-GAAP adjustments | 0.06 | 0.07 | -0.12 | 0.19 | 0.18 |
| Non-GAAP adjustments: | Non-GAAP net loss per share – basic | -0.04 | -0.04 | $- | -0.11 | $- |
| Non-GAAP adjustments: | GAAP net income (loss) per share – diluted | -0.1 | -0.11 | 0.11 | -0.3 | -0.18 |
| Non-GAAP adjustments: | Non-GAAP adjustments | 0.06 | 0.07 | -0.11 | 0.19 | 0.18 |
| Non-GAAP adjustments: | Non-GAAP net loss per share – diluted | -0.04 | -0.04 | $- | -0.11 | $- |
Balance Sheet
June 30, 2025 — Condensed Consolidated Balance Sheets (in thousands)
| March 31, 2026 (unaudited) | June 30, 2025 | ||
|---|---|---|---|
| Current assets: | Cash and cash equivalents | 37,780 | 3,628 |
| Current assets: | Certificate of deposit | 12,112 | |
| Current assets: | Accounts receivable | 1,062 | 962 |
| Current assets: | Prepaids and other current assets | 1,332 | 633 |
| Current assets: | Total current assets | 40,174 | 17,335 |
| Property and equipment: | Equipment | 2,131 | 1,692 |
| Property and equipment: | Leasehold improvements | 547 | 547 |
| Property and equipment: | Accumulated depreciation | -1,344 | -1,021 |
| Property and equipment: | Property and equipment, net | 1,334 | 1,218 |
| Property and equipment: | Right of use asset - operating | 987 | 836 |
| Property and equipment: | Other assets | 22 | 17 |
| Property and equipment: | Total assets | 42,517 | 19,406 |
| Current liabilities: | Accounts payable | 973 | 361 |
| Current liabilities: | Accrued expenses and other current liabilities | 370 | 206 |
| Current liabilities: | Lease liability - operating, current portion | 196 | 138 |
| Current liabilities: | Total current liabilities | 1,539 | 705 |
| Current liabilities: | Lease liability - operating, long-term portion | 893 | 803 |
| Current liabilities: | Total liabilities | 2,432 | 1,508 |
| Stockholders’ equity: | Common stock | 2 | 2 |
| Stockholders’ equity: | Additional paid-in capital | 61,875 | 34,542 |
| Stockholders’ equity: | Accumulated deficit | -21,792 | -16,646 |
| Stockholders’ equity: | Total stockholders’ equity | 40,085 | 17,898 |
| Stockholders’ equity: | Total liabilities and stockholders’ equity | 42,517 | 19,406 |
Cash Flow
Nine Months Ended March 31, — Condensed Consolidated Statements of Cash Flows (unaudited) (in thousands)
| Nine Months Ended March 31, – 2026 | Nine Months Ended March 31, – 2025 | ||
|---|---|---|---|
| Operating activities: | Net loss | -5,146 | -2,164 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Amortization of deferred compensation | 17 | |
| Adjustments to reconcile net loss to net cash used in operating activities: | Stock-based compensation expense | 3,211 | 1,149 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Depreciation and amortization expense | 325 | 307 |
| Adjustments to reconcile net loss to net cash used in operating activities: | Amortization of discount on convertible notes | 715 |
Full release
Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company’s expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company’s current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,”
“could,” “would,” “should,” “anticipate,” “predict,” “potential,”
“continue,” “expect,” “intend,” “plan,” “project,” “believe,”
“estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company’s control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise... (truncated)flect events or circumstances in the future, even if new information becomes available.
About Aeluma, Inc.
Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum.
Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.
Company:
Aeluma, Inc.
(805) 351-2707 info@aeluma.com
Investor Contact:
Financial Profiles, Inc.
Alex Villalta
(310) 622-8227 ir@aeluma.com⁴
Aeluma, Inc. and Subsidiary
Condensed Consolidated Balance Sheets⁵
Aeluma, Inc. and Subsidiary
Condensed Consolidated Statements of Operations
(unaudited)⁶
Aeluma, Inc. and Subsidiary
Condensed Consolidated Statements of Cash Flows
(unaudited)⁷
Aeluma, Inc. and Subsidiary
Reconciliation of GAAP and Non-GAAP Financial
Measures (unaudited)⁸